Multiple sclerosis-like disease secondary to alpha interferon

By Matsuo Toshihiko   Takabatake Ryu  

Ocular Immunology and Inflammation, Vol. 10, Iss. 4, 2002-12 ,pp. : 299-304

Informa Healthcare

Access to resources Recommend Favorite

Interferon gamma responses to myelin peptides in multiple sclerosis correlate with a new clinical measure of disease progression

By Moldovan I.R.   Rudick R.A.   Cotleur A.C.   Born S.E.   Lee J.-C.   Karafa M.T.   Pelfrey C.M.  

Journal of Neuroimmunology, Vol. 141, Iss. 1, 2003-08 ,pp. : 132-140

Elsevier

Access to resources Recommend Favorite

Interferon Beta in Multiple Sclerosis

By Arnason B.G.W.  

Clinical Immunology, Vol. 81, Iss. 1, 1996-10 ,pp. : 1-11

Academic Press

Access to resources Recommend Favorite

In Vitro Assessment of the Biologic Activity of Interferon Beta Formulations used for the Treatment of Relapsing Multiple Sclerosis

By            

Journal of Immunoassay and Immunochemistry, Vol. 35, Iss. 3, 2014-07 ,pp. : 288-299

Taylor & Francis Ltd

Access to resources Recommend Favorite

Impact of type-I-interferon on monocyte subsets and their differentiation to dendritic cells - An in vivo and ex vivo study in multiple sclerosis patients treated with interferon-beta

By Bergh F.T.   Dayyani F.   Ziegler-Heitbrock L.  

Journal of Neuroimmunology, Vol. 146, Iss. 1, 2004-01 ,pp. : 176-188

Elsevier

Access to resources Recommend Favorite